China Universal Asset Management Company’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
SL
China Universal Asset Management Company's DYN Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Dyne Therapeutics (DYN) stake by 10% in Q2 2026, selling an estimated $54.1K and leaving 26,310 shares worth $584K. The position accounts for 0.03% of the portfolio, ranked #250.
China Universal Asset Management Company first reported a position in DYN in Q3 2022 and has held it in 16 quarters since. The position peaked at $694K in Q3 2024. 141 funds tracked by Wall St. Rank hold DYN as of Q2 2026.
- China Universal Asset Management Company held 26,310 shares of Dyne Therapeutics worth $584K as of Q2 2026.
- China Universal Asset Management Company sold 2,909 Dyne Therapeutics shares in Q2 2026, an estimated $54.1K.
- Dyne Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #250 holding.
- China Universal Asset Management Company first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Dyne Therapeutics position peaked at $694K in Q3 2024.
- 141 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.